In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of my favorite stocks. Shares have jumped by more than 20,000% since then.

I believe we are about to do it again with this new AI project called Stargate

Lisa Evoli Biography and Net Worth

EVP of Integra LifeSciences

Lisa Evoli is the executive vice president and chief human resources officer. She is responsible for developing and executing the overall human resources strategy for the company. Ms. Evoli joined Integra in 2016, bringing extensive global human resources leadership experience.

Prior to joining Integra, she served as vice president, human resources for the data and devices division of TE Connectivity, formerly Tyco Electronics. Prior to working for TE Connectivity, she held senior global human resources leadership positions at Johnson & Johnson in the pharmaceutical and consumer businesses. Ms. Evoli also held various global human resources leadership roles at Motorola’s broadband communications and automotive groups and also assumed a leadership role for the company’s talent management and organizational development function.

Ms. Evoli received her bachelor's degree in business administration from California University of Pennsylvania and a master's degree in human resources and organizational development from Villanova University.

What is Lisa Evoli's net worth?: The estimated net worth of Lisa Evoli is at least $426,612.65 as of February 27th, 2023. Ms. Evoli owns 18,605 shares of Integra LifeSciences stock worth more than $426,613 as of November 21st. This net worth evaluation does not reflect any other assets that Ms. Evoli may own. Learn More about Lisa Evoli's net worth.
How do I contact Lisa Evoli?: The corporate mailing address for Ms. Evoli and other Integra LifeSciences executives is 311 ENTERPRISE DRIVE, PLAINSBORO NJ, 08536. Integra LifeSciences can also be reached via phone at (609) 275-0500 and via email at [email protected]. Learn More on Lisa Evoli's contact information.
Has Lisa Evoli been buying or selling shares of Integra LifeSciences?: Lisa Evoli has not been actively trading shares of Integra LifeSciences during the last quarter. Most recently, Lisa Evoli sold 3,767 shares of the business's stock in a transaction on Monday, February 27th. The shares were sold at an average price of $57.00, for a transaction totalling $214,719.00. Following the completion of the sale, the executive vice president now directly owns 18,605 shares of the company's stock, valued at $1,060,485. Learn More on Lisa Evoli's trading history.
Who are Integra LifeSciences' active insiders?: Integra LifeSciences' insider roster includes Richard Caruso (Major Shareholder), Glenn Coleman (COO), Jan De Witte (CEO), Stuart Essig (Director), Lisa Evoli (EVP), Michael McBreen (EVP), Jeffrey Mosebrook (SVP), Raymond Murphy (Director), and Eric Schwartz (EVP). Learn More on Integra LifeSciences' active insiders.
Are insiders buying or selling shares of Integra LifeSciences?: In the last year, Integra LifeSciences insiders bought shares 1 times. They purchased a total of 52,641 shares worth more than $1,499,742.09. The most recent insider tranaction occured on May, 23rd when Chairman Stuart Essig bought 52,641 shares worth more than $1,499,742.09. Insiders at Integra LifeSciences own 3.1% of the company. Learn More about insider trades at Integra LifeSciences.
Information on this page was last updated on 5/23/2024.

Lisa Evoli Insider Trading History at Integra LifeSciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/27/2023	Sell	3,767	$57.00	$214,719.00	18,605
8/10/2022	Sell	1,165	$55.81	$65,018.65	17,997
6/15/2022	Sell	900	$55.93	$50,337.00	19,911
5/24/2022	Sell	250	$59.85	$14,962.50	20,811
5/10/2021	Sell	5,335	$75.00	$400,125.00	10,415
4/14/2021	Sell	6,306	$70.00	$441,420.00	7,825
6/5/2020	Sell	3,475	$55.00	$191,125.00	6,455
7/29/2019	Sell	2,380	$63.00	$149,940.00	2,588
3/15/2019	Sell	1,291	$55.90	$72,166.90	4,968

Lisa Evoli Buying and Selling Activity at Integra LifeSciences

Integra LifeSciences Company Overview

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Today's Range

Now: $22.93

$22.32

$22.95

50 Day Range

MA: $19.85

$16.95

$26.70

2 Week Range

Now: $22.93

$16.81

$45.42

Volume

366,165 shs

Average Volume

1,052,990 shs

Market Capitalization

$1.77 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.08

Bill Gates’s Next Big AI Bet: Stargate

From Brownstone Research | Ad